- SLRN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Acelyrin (SLRN) 8-K13 Aug 24Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial ResultsFinancial data
Company Profile